On January 4, 2021 IMV Inc. ("IMV" or the "Corporation") (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company pioneering a novel class of cancer immunotherapies and vaccines against infectious diseases, reported that IMV’s executive management team will participate at two upcoming virtual investor events (Press release, IMV, JAN 4, 2021, View Source [SID1234573400]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

BTIG Fireside Chat with IMV
Date: Thursday, January 7, 2021
Time: 12:15 PM ET

H.C. Wainwright Fireside Chat with IMV (Bioconnect 2021 Conference)
Date: Monday January 11, 2021 (on demand for one week)
Time: Starting at 6:00 AM ET

A webcast of these events will be available under "Events, Webcasts and Presentations" in the investors section of IMV’s website and a replay will be available shortly afterwards for approximately 30 days.